[
  {"domain_id":"CQ","domain_name":"Credit Quality","domain_description":"PD, Rating, DSCR, LTV, Criticized","icon":"BarChart3","color":"#1e40af","regulatory_relevance":["FR Y-14Q","SNC","Interagency CRE"],"primary_stakeholders":["CRO","Credit Committee"]},
  {"domain_id":"EX","domain_name":"Exposure","domain_description":"Outstanding, Committed, Utilized, Undrawn, EAD","icon":"Wallet","color":"#7c3aed","regulatory_relevance":["FR Y-14Q","Basel SA"],"primary_stakeholders":["CRO","Treasury"]},
  {"domain_id":"PR","domain_name":"Profitability","domain_description":"Revenue, NIM, ROE, ROA, All-In Rate, Spread","icon":"TrendingUp","color":"#059669","regulatory_relevance":["Pillar 3","SEC"],"primary_stakeholders":["CFO","Desk Heads"]},
  {"domain_id":"LP","domain_name":"Loss & Provision","domain_description":"EL Rate, EL Dollar, LGD, CECL Allowance","icon":"AlertTriangle","color":"#dc2626","regulatory_relevance":["ASC 326","IFRS 9","FR Y-14Q"],"primary_stakeholders":["CFO","CRO"]},
  {"domain_id":"CA","domain_name":"Capital","domain_description":"RWA, Capital Allocated, Leverage Ratio","icon":"Building2","color":"#b45309","regulatory_relevance":["Basel III","FR Y-14Q","CCAR"],"primary_stakeholders":["CFO","Treasury"]},
  {"domain_id":"PC","domain_name":"Pricing","domain_description":"Spread, Fee Rate, All-In Rate, Pricing Exceptions","icon":"Tag","color":"#0891b2","regulatory_relevance":["SR 13-3","Pillar 3"],"primary_stakeholders":["Desk Heads","CRO"]},
  {"domain_id":"PO","domain_name":"Portfolio Composition","domain_description":"Tenor, Concentration, Collateral, Maturity","icon":"Target","color":"#6d28d9","regulatory_relevance":["FR Y-14Q","Concentration limits"],"primary_stakeholders":["CRO"]},
  {"domain_id":"EW","domain_name":"Early Warning","domain_description":"Rating Migration, PD Divergence, Utilization Trend, Amendment Activity","icon":"Bell","color":"#e11d48","regulatory_relevance":["SR 11-7","OCC Handbook"],"primary_stakeholders":["CRO","Special Assets"]}
]
